Sygen is an indigenous pharmaceutical company incorporated in 2019 to acquire the key operating assets of Nigerian German Chemicals (NGC). Prior to its acquisition NGC remained a well-known brand in Nigeria with operations spanning over 50 years.
Sygen produces and distributes pharmaceuticals products covering Analgesic, Anti-Diabetics, Antifungal, Anti-spasmodic, Cough medications and Hematinic drugs segments under the NGC brand name. The company also manufactures beverage and bottled water. The Company operates a factory in Ogun state, south west Nigeria and eight depots across the country.
Sygen’s vision is to build a leading pharmaceutical business focused on manufacturing and distributing affordable quality drugs that are readily available and easily accessible to the middle and lower-income demographic of the economy.
